We expect Talaris Therapeutics Inc (TALS) stock to go up on 23 June Friday tomorrow based on our mathematical analysis model.
Related News:
Talaris Therapeutics, Inc. Announces Leadership Changes
Talaris Therapeutics, Inc. announced the appointment of Mary Kay Fenton as interim chief executive officer, effective May 26, 2023. Ms. Fenton, who will remain the company’s chief financial officer, succeeds chief executive officer Scott Requadt, who will leave the company. as part of a planned workforce reduction, as the company previously announced. The company is currently undertaking a comprehensive review of strategic alternatives aimed at maximizing shareholder value, including potential business combinations and/or a divestiture of the company’s CMC cell therapy capabilities.
The company has not set a timeline for the completion of this strategic review and does not intend to comment further on the status of this process unless or until its board of directors has approved a final action plan, or it is determined that other information is appropriate.